Why is Beryl Drugs falling/rising?

As of 29-Oct, Beryl Drugs Ltd's stock price is currently at Rs 24.00, reflecting an increase of Rs 1.0 or 4.35%. The stock has been gaining for the last two days, with a total return of 4.39% during this period. It has outperformed its sector by 3.61% today and reached an intraday high of Rs 27.6, which is a 20% increase. However, despite these positive movements, the stock has shown a significant year-to-date decline of 33.61% and a one-year decline of 35.12%. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 69.25% against the five-day average, indicating a potential concern regarding sustained interest in the stock.
Broader Market Context: In the short term, Beryl Drugs has outperformed the Sensex, with a one-week return of 7.62% compared to the benchmark's 0.68%. This indicates that while the stock is experiencing a positive momentum recently, it has struggled significantly over the longer term, as evidenced by its year-to-date and one-year performance compared to the Sensex, which has gained 8.78% year-to-date. The stock's high volatility today, with an intraday volatility of 9.09%, suggests that while there is some excitement around the stock, the fluctuations may also reflect uncertainty among investors.